A Vision of Future Treatment in Chagas Heart Disease

[...]to counteract the pathogenic potency of beta1-AABs, but presently only directed to beta1-AAB-positive patients with idiopathic dilated cardiomyopathy, new treatment strategies are under study that focus on beta1-AAB removal via an apheresis technique or drug treatment for in vivo beta1-AAB neut...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2014-03, Vol.63 (10), p.1027-1027
Hauptverfasser: Wallukat, Gerd, PhD, Haberland, Annekathrin, PhD, Schimke, Ingolf, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]to counteract the pathogenic potency of beta1-AABs, but presently only directed to beta1-AAB-positive patients with idiopathic dilated cardiomyopathy, new treatment strategies are under study that focus on beta1-AAB removal via an apheresis technique or drug treatment for in vivo beta1-AAB neutralization (2).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2013.08.1660